PPARA and focal segmental glomerulosclerosis: To study the effect of PPARɣ agonism on glomerular HPSE and HS expression in vivo, adriamycin nephropathy (AN; an animal model for human FSGS) was induced in rats that were subsequently treated with the PPARɣ agonist pioglitazone or vehicle for 6 weeks.